跳至主要内容
临床试验/CTRI/2021/02/031514
CTRI/2021/02/031514尚未招募未知

Methylene blue versus Vasopressin Infusion in patients of septic Shock requiring high dose Noradrenaline support: A Prospective Randomized study

Institute of Medical Sciences BH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age group between 18-65 years.
  • 2.Patients fulfilling the above criteria for septic shock (Sepsis-3 definition)
  • 3.Patients who required Noradrenaline support of >= 0.2 µg/kg/min to maintain MAP of 65-70 mm Hg.

排除标准

  • 1. Patient refusal.
  • 2. Patients who were pregnant
  • 3. Patients with known sensitivity to Methylene Blue.
  • 4. Patient age less than 18 years.
  • 5. Patients with known H/O G6PD disease, valvular heart disease, present or suspected coronary heart disease, and present or suspected acute mesenteric ischemia or vasoplastic diathesis.

研究者

发起方
Institute of Medical Sciences BH

相似试验

尚未招募
3 期
Two different medicines named Methylene blue and vasopressin will be compared as second line blood pressure raising medication in patients having infection with low blood pressure
CTRI/2024/08/072434All India Institute Of Medical Sciences New Delhi
尚未招募
不适用
Effect of methylene blue(drug used in very low blood pressure) in critically ill patients
CTRI/2021/12/038542one
已完成
2 期
Infusion of low dose of vasopressin versus phenylephrine for prevention of cardiopulmonary bypass induced vasoplegic syndrome in patients undergoing coronary artery bypass grafting surgeryCardiopulmonary bypass induced vasoplegic shock.Diseases of arteries, arterioles and capillariesI70-I79
IRCT201408201127N2Vice Chancellor for Research of Tabriz University of Medical Sciences75
Unknown
2 期
Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm NeonateRefractory ShockNeonatal Sepsis
NCT04110418Ain Shams University36
进行中(未招募)
1 期
Administration of Vasopressin and Methylprednisolone to Improve Survival Following In-Hospital Cardiac ArrestThe study will include patients with in-hospital cardiac arrest (IHCA). The study will test whether treatment with methylprednisolone and vasopressin added to standard care will improve survival following IHCA. The study is a multicenter, double-blind, placebo-controlled trial.MedDRA version: 20.0Level: PTClassification code 10007515Term: Cardiac arrestSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2017-004773-13-DKResearch Center for Emergency Medicine Department of Clinical Medicine Aarhus University501